PEN Penumbra Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PEN

Price (delayed)

$208.46

Market cap

$8.07B

P/E Ratio

87.96

Dividend/share

N/A

EPS

$2.37

Enterprise value

$8.14B

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses ...

Highlights
The net income has soared by 124% from the previous quarter
PEN's EPS has soared by 124% QoQ
Penumbra's debt has increased by 2.4% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.penumbrainc.com
Peers: NVRO OFIX NURO

Key stats

What are the main financial stats of PEN
Market
Shares outstanding
38.7M
Market cap
$8.07B
Enterprise value
$8.14B
Valuations
Price to earnings (P/E)
87.96
Price to book (P/B)
6.82
Price to sales (P/S)
7.56
EV/EBIT
102.13
EV/EBITDA
76.09
EV/Sales
7.69
Earnings
Revenue
$1.06B
EBIT
$79.65M
EBITDA
$106.91M
Free cash flow
$82.12M
Per share
EPS
$2.37
Free cash flow per share
$2.14
Book value per share
$30.55
Revenue per share
$27.56
TBVPS
$34.35
Balance sheet
Total assets
$1.56B
Total liabilities
$377.36M
Debt
$234.34M
Equity
$1.18B
Working capital
$764.26M
Liquidity
Debt to equity
0.2
Current ratio
6.06
Quick ratio
3.25
Net debt/EBITDA
0.63
Margins
EBITDA margin
10.1%
Gross margin
64.5%
Net margin
8.6%
Operating margin
6.9%
Efficiency
Return on assets
6.2%
Return on equity
8.3%
Return on invested capital
6.7%
Return on capital employed
5.7%
Return on sales
7.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PEN stock price

How has the Penumbra stock price performed over time
Intraday
1.16%
1 week
1.98%
1 month
-3.04%
1 year
-30.75%
YTD
-17.13%
QTD
-6.6%

Financial performance

How have Penumbra's revenue and profit performed over time
Revenue
$1.06B
Gross profit
$682.64M
Operating income
$73.55M
Net income
$90.95M
Gross margin
64.5%
Net margin
8.6%
The net income has soared by 124% from the previous quarter
Penumbra's net margin has surged by 110% QoQ
Penumbra's operating income has surged by 70% QoQ
PEN's operating margin has soared by 57% from the previous quarter

Growth

What is Penumbra's growth rate over time

Valuation

What is Penumbra stock price valuation
PEN P/E details
P/E
87.96
P/B
6.82
P/S
7.56
EV/EBIT
102.13
EV/EBITDA
76.09
EV/Sales
7.69
PEN's EPS has soared by 124% QoQ
The price to earnings (P/E) is 86% lower than the last 4 quarters average of 606.6
The stock's P/B is 36% below its 5-year quarterly average of 10.6 and 31% below its last 4 quarters average of 9.8
PEN's equity is up by 18% year-on-year and by 7% since the previous quarter
PEN's price to sales (P/S) is 34% lower than its 5-year quarterly average of 11.4 and 33% lower than its last 4 quarters average of 11.1
PEN's revenue is up by 25% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Penumbra business performance
The ROA has soared by 114% from the previous quarter
The ROE has soared by 113% from the previous quarter
The company's return on invested capital has surged by 60% QoQ
PEN's ROS has soared by 53% QoQ

Dividends

What is PEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PEN.

Financial health

How did Penumbra financials performed over time
Penumbra's quick ratio has increased by 20% YoY and by 3.5% QoQ
Penumbra's current ratio has increased by 16% YoY
Penumbra's debt is 80% lower than its equity
PEN's equity is up by 18% year-on-year and by 7% since the previous quarter
PEN's debt to equity is down by 17% year-on-year and by 4.8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.